DVA vs ISPC · P/E 14, rev $12.82B vs rev $9.3M
DaVita HealthCare Partners Inc (DVA) versus iSpecimen Inc (ISPC) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. ISPC currently screens at market cap $4.4M.
Not investment advice. Open the DVA and ISPC stock pages for the full models.
Not investment advice.